SCHEMBL2931838

SCHEMBL2931838

CN1CCN(Cc2ccccc2Br)CC1

nearest known ligand 0.87

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 6/20 0.69
CYP2A13 Q16696 1/20 0.64
ALDH1A1 P00352 5/20 0.56
KDM4E B2RXH2 4/20 0.56
LMNA P02545 1/20 0.56
MC4R P32245 1/20 0.56
CHRNA7 P36544 1/20 0.55
ATM Q13315 1/20 0.54
TSHR P16473 1/20 0.54
RECQL P46063 1/20 0.54
L3MBTL1 Q9Y468 1/20 0.54
POLB P06746 1/20 0.53
FAAH O00519 1/20 0.52
CYP3A4 P08684 1/20 0.52
CYP2D6 P10635 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7447200 0.82 CYP2A13 (0.70) HTR6CYP2A13ALDH1A1KDM4ELMNA
SCHEMBL18356563 0.81 ALDH1A1 (0.71) HTR6CYP2A13ALDH1A1KDM4ELMNA
SCHEMBL2935951 0.80 MEN1 (0.52) HTR6ALDH1A1KDM4ECHRNA7POLB
SCHEMBL11891934 0.79 KMT2A (0.73) HTR6CYP2A13ALDH1A1KDM4ELMNA
SCHEMBL6818375 0.79 ALDH1A1 (0.69) HTR6CYP2A13ALDH1A1KDM4ELMNA
SCHEMBL13469106 0.79 MC4R (0.58) HTR6ALDH1A1KDM4EMC4RCHRNA7
SCHEMBL8162127 0.79 KDM4E (0.66) CYP2A13ALDH1A1KDM4ELMNAATM
SCHEMBL14986322 0.78 ALDH1A1 (0.68) HTR6CYP2A13ALDH1A1KDM4ELMNA
SCHEMBL3412153 0.78 MC4R (0.56) HTR6ALDH1A1KDM4ELMNAMC4R
SCHEMBL17706256 0.78 MC4R (0.56) HTR6ALDH1A1KDM4ELMNAMC4R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2229377-A1 5-ALKYL/ALKENYL-3-CYANOPYRIDINES AS KINASE INHIBITORS Wyeth LLC (US) 2010-09-22 EP disclosed
WO-2009076602-A1 5-ALKYL/ALKENYL-3-CYANOPYRIDINES AS KINASE INHIBITORS WYETH (US) 2009-06-18 WO disclosed
WO-2007075555-A2 COMBINATION OF AN H3 ANTAGONIST/INVERSE AGONIST AND AN APPETITE SUPPRESSANT SCHERING CORPORATION (US) 2007-07-05 WO disclosed